Modapil, Mohadjer .
HRN: 23-35-40 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2023
AMPICILLIN 1GM (VIAL)
07/17/2023
07/23/2023
IVT
75 Mg
Q12
Neonatal Sepsis
Waiting Final Action
07/18/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/18/2023
07/24/2023
IVTT
22.5mg LD
Q8h
Neonatal Sepsis
Checking Final Appropriateness
07/18/2023
AMPICILLIN 250MG (VIAL)
07/18/2023
07/24/2023
IVTT
100mg
Q12
Neonatal Sepsis
Checking Final Appropriateness
07/25/2023
CEFOTAXIME 500MG (VIAL)
07/25/2023
08/06/2023
IVTT
150mg
Q12
Neonatal Sepsis
Checking Final Appropriateness
07/25/2023
CEFOTAXIME 500MG (VIAL)
07/25/2023
08/16/2023
IVTT
150mg
Q12
Neonatal Sepsis
Checking Final Appropriateness
07/25/2023
AMPICILLIN 1GM (VIAL)
07/25/2023
08/06/2023
IVTT
100mg
Q12
Neonatal Sepsis
Checking Final Appropriateness